Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
1,391,267
-
Share change
-
-559,813
-
Total reported value
-
$92,698,931
-
Put/Call ratio
-
345%
-
Price per share
-
$66.48
-
Number of holders
-
48
-
Value change
-
-$36,792,997
-
Number of buys
-
14
-
Number of sells
-
22
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q4 2020
As of 31 Dec 2020,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,391,267 shares.
The largest 10 holders included
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), Clough Capital Partners L P, GOLDMAN SACHS GROUP INC, Brinker Capital Investments, LLC, 20/20 Capital Management, Inc., Orion Portfolio Solutions, LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BANK OF AMERICA CORP /DE/, and ROYAL BANK OF CANADA.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.